| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 39,475 | 41,110 | 38,016 | 34,069 | | Cost of Revenue | 23,136 | 24,806 | 24,271 | 20,504 | | | Gross Profit | 16,339 | 16,304 | 13,746 | 13,564 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,516 | 13,296 | 11,770 | 11,049 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 449 | 465 | 393 | 390 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,375 | 2,543 | 1,583 | 2,125 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 840 | 81 | 5 | (28) | | Earnings Before Interest And Taxes | 3,215 | 2,624 | 1,588 | 2,097 | | Interest Expense | 39 | 35 | (203) | 129 | | Income Before Tax | 3,176 | 2,589 | 1,792 | 1,968 | | Income Tax Expense | 1,073 | 987 | (399) | 802 | | Minority Interest | (703) | (538) | (464) | (197) | | | | Net Income From Continuing Ops | 1,400 | 1,064 | 1,726 | 968 | | | Non-recurring Events | | Discontinued Operations |
-
| (5) | (5) | (3) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,400 | 1,060 | 1,722 | 965 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,400 | $1,060 | $1,722 | $965 |
|
0.59% Nasdaq 
Income Statement
